Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
Proteostasis, Astellas Join up on Genetic Disease Drugs 11/04/14 Boston
Canaan Closes $675M Fund, One Of Venture’s Ten Largest This Year 10/16/14 New York
Orphan Drug From Scioderm Aims to Treat Rare Skin Disease 10/07/14 Raleigh Durham
Hear Epizyme, Sage, Zafgen Share Their Stories on Oct. 8 09/11/14 Boston
Which Countries Excel in Creating New Drugs? It’s Complicated 09/02/14 Seattle
Standing on a Ledge Once Again, Amicus Holds Breath for Latest Study 08/11/14 New York
East Coast Biotech Roundup: Acceleron, Seres, Sage, & More 07/18/14 Boston
Oh Canada! Versant’s Strategic Shifts Lead to $300M Fund 07/08/14 San Francisco
Sage Therapeutics Readies IPO Pitch to Develop CNS Drugs 06/18/14 Boston
Promedior Sees Hope in Small Myelofibrosis Study 05/30/14 Boston
West Coast Biotech Roundup: Lumena/Shire, Isis, Janssen Labs & More 05/16/14 San Diego
Shire Pays Over $260M Upfront in IPO Detour for San Diego’s Lumena 05/12/14 National
East Coast Biotech Roundup: Neurophage, Boston Biotech, Insmed, & More 03/28/14 Boston
Neurophage Nabs $17M More to Hunt Down Brain Plaques 03/25/14 Boston
Proteon, Looking Past Ill-Fated Novartis Deal, Goes it Alone 03/18/14 Boston
Get a Shot, Have Some Bread: ImmusanT’s Plan For a Celiac Vaccine 03/11/14 Boston
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
Hunting For Brain Plaques, Neurophage Turns to a Virus 01/31/14 Boston
San Diego Life Sciences Roundup: Shire, Illumina, Tandem, and More 01/24/14 San Diego
With Dermagraft Sale, Shire Jettisons Business Acquired 3 Years Ago 01/22/14 San Diego
Sangamo, Biogen Team up to Make Drugs For Blood Disorders 01/09/14 San Francisco
Histogen Wins Legal Ruling in Saga of Entrepreneurial Perseverance 08/26/13 San Diego
East Coast Life Sciences Roundup: Epizyme, Rodin, Ophthotech, & More 08/16/13 Boston
Sage Taps Former Shire Exec to Lead CNS Drugs Into Clinical Trials 08/14/13 Boston
NEA, Genzyme Join $18M Round For Rare Disease Startup Edimer 07/30/13 Boston
Bluebird Prices Ahead of Range, Takes Flight on Nasdaq Today 06/19/13 Boston
East Coast Life Sciences Roundup: Dunsire, Good Start, Nimbus, & More 05/10/13 Boston
Nimbus Discovery, Shire to Co-Develop Oral Rare Disease Drugs 05/08/13 Boston
Former Keryx Exec’s Mission: Turn TG Into the Next Pharmacyclics 05/06/13 New York
Page 1 of 4 next page »